Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

Compare

3.600

+0.120 (3.45%)

At close: Feb 6, 2026, 4:00 PM EST

3.590

-0.010 (-0.28%)

After-hours: Feb 6, 2026, 7:31 PM EST

Grace Therapeutics Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	-	-	-	-	-	0.2
Cost of Revenue	-	-	-	-	-	0.08
Gross Profit	-	-	-	-	-	0.12
Selling, General & Admin	7.16	7.17	6.68	8.28	6.58	6.66
Research & Development	5.35	9.51	4.59	9.93	5.56	4.17
Operating Expenses	12.5	16.68	11.28	18.21	12.14	10.84
Operating Income	-12.5	-16.68	-11.28	-18.21	-12.14	-10.72
Interest Expense	-	-	-	-	-	-0.26
Interest & Investment Income	0.68	0.71	0.91	0.25	0.08	0.11
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.02	-0.07	-0.3	-0.68
Other Non Operating Income (Expenses)	2.4	3.22	-2.73	0.01	5.34	-2.43
EBT Excluding Unusual Items	-9.44	-12.77	-13.11	-18.02	-7.02	-13.98
Merger & Restructuring Charges	-	-	-1.49	-33.51	-3.2	-
Asset Writedown	-0	-0	-0.09	-0.44	-0.25	-5.7
Pretax Income	-9.44	-12.77	-14.69	-51.97	-10.47	-19.68
Income Tax Expense	-1.62	-3.2	-1.83	-9.54	-0.65	-
Net Income	-7.82	-9.57	-12.85	-42.43	-9.82	-19.68
Net Income to Common	-7.82	-9.57	-12.85	-42.43	-9.82	-19.68
Shares Outstanding (Basic)	14	12	10	7	6	2
Shares Outstanding (Diluted)	14	12	10	7	6	2
Shares Change (YoY)	23.94%	26.85%	28.16%	21.09%	148.46%	40.25%
EPS (Basic)	-0.55	-0.79	-1.35	-5.71	-1.60	-7.96
EPS (Diluted)	-0.55	-0.79	-1.35	-5.71	-1.60	-7.96
Free Cash Flow	-12.01	-14.9	-12.36	-15.93	-17.23	-14.39
Free Cash Flow Per Share	-0.84	-1.23	-1.30	-2.14	-2.81	-5.82
Gross Margin	-	-	-	-	-	61.22%
Operating Margin	-	-	-	-	-	-5467.35%
Profit Margin	-	-	-	-	-	-10039.80%
Free Cash Flow Margin	-	-	-	-	-	-7340.82%
EBITDA	-12.5	-16.67	-11.27	-18.08	-11.22	-9.79
D&A For EBITDA	0.01	0.01	0.01	0.12	0.92	0.92
EBIT	-12.5	-16.68	-11.28	-18.21	-12.14	-10.72

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q